FDA Investigator Frances Namuswe, PhD

Frances Namuswe, PhD has conducted inspections on 5 sites in 3 countries as of 23 Apr 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
5
Last Inspection Date:
23 Apr 2019
Investigator Role:
FDA Investigator
Redica ID:
100004458
Countries of Inspections:
United States of America, Korea (Republic of), Switzerland
FDA Investigators that have inspected at least one site in common with Frances Namuswe, PhD:
Alice S Tsao, Amalia C Himaya, Amanda L Fyles, Amy Devlin, PhD, Anastasia G Lolas, Andrea Siegel, PhD, Anita Narula, PhD, Anjali Shukla, PhD, Ashutosh Rao, PhD, Barry Cherney, PhD, Bichsa T Tran, Bo Chi, PhD, Brandon C Heitmeier, Brian M Janelsins, PhD, Brien C Fox, Brooke K Higgins, Bryan A Galvez, Carla J Lundi, Caryn M Mcnab, Chaltu Nwakijra, Cheron M Portee, Christina C Santos, Christina V Santos, Christopher R Czajka, Daniel W Cline, Davinna Ligons, PhD, Diane Cvan Leeuwen, Diane L Raccasi, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Donna Ltartaglino Besone, Dr. Jun Liu, PhD, Dr. Ralph M Bernstein, PhD, Dr. Zhihao Qiu (Peter), PhD, Esther C Broner, PhD, Gerald B Seaborn, Jr, Haley H Seymour, Haroon Vohra (NMI), Hasan A Irier, PhD, Herbert M Corbello, Ian L Mcwilliams, Iris C Macinnes, Ivis L Negron, James R Fleckenstein, Jee Chung, PhD, Jeffrey P Raimondi, Jennifer Gogley, Jennifer M Gogley, Jennifer Swisher, PhD, Joel Welch, PhD, John R Myung, Jonathan W Chapman, Jorge L Guadalupe, Juan Rjimenez Garcia, Juhong Liu, PhD, Junho Pak, Ka L Wong, Kalavati Suvarna, PhD, Katherine Szestypalow, Kathleen R Jones, PhD, Kathy Lee, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kevin A Gonzalez, Kim Lthomas Cruse, Kristen Nickens, PhD, Laura Fontan, MS, Leonard H Lavi, Libia M Lugo, Lindsey Brown, PhD, LT Richard A Lyght, Madushini Dharmasena, PhD, Marcia B Williams, Marcus F Yambot, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Mary E Farbman, PhD, Mary E Storch, Maxyne T Lam, Meredith P Soehl, Investigator, Michael Shanks, MS, Michelle A Marsh, Mihaly S Ligmond, Mohsen Rajabi Abhari, FDA, Nadeem I Chaudhry, Nebil A Oumer, Nicholas Obiri, PhD, Nicola M Fenty Stewart, Omotunde O Osunsanmi, Peter S Diak, Rachel C Harrington, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Richmond K Yip, Riley C Myers, PhD, Robert D Tollefsen, Robert Darius, Robert Rodriguez, Roger F Zabinski, Rona Leblanc, PhD, Ronald L Koller, Ronda Leblanc, Santos E Camara, Sarah Arden, Scott N Lim, Scott R Nichols, PhD, Seneca D Toms, Shadia Zaman, PhD, Sidney B Priesmeyer, Sonia R Peterson, Stanley Au, Steven E Bowen, PhD, Steven Fong, MS, PhD, Susan P Bruederle, Taichun Qin, PhD, Tamika White, Teegan Dellibovi Ragheb, PhD, Terri L Dodds, Thao T Kwan, Thao X Tran, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tracy Denison, PhD, Uttaniti Limchumroon (Tom), Vaishali J Patel, Viviana Matta, Wendy G Tan, PhD, William Hallett, PhD, Xiaokuang Lai, PhD, Xiaoshi N Wang, Yi Wang, PhD, Ying Xin Fan, PhD, Yumi J Hiramine, Yun Wu, PhD, Yvonne C Wilkes, Zhong Li, PhD

Frances Namuswe, PhD's Documents

Publish Date Document Type Title
July, 2015 FDA 483 Human Genome Sciences, Inc. - Form 483, 2015-07-24
March, 2018 FDA 483 Response Amgen, Inc - Form 483R, 2018-04-05
March, 2018 FDA 483 Amgen, Inc - Form 483, 2018-03-16
May, 2019 FDA 483 Tanvex BioPharma USA, Inc - Form 483, 2019-05-02
December, 2017 FDA 483 Lonza AG - Form 483, 2017-12-15

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more